What is the projected market valuation for the Agriculture Biological Control Agents Market in 2035?

The projected market valuation for the Agriculture Biological Control Agents Market in 2035 is 20.7 USD Billion. Read More

What was the market valuation for the Agriculture Biological Control Agents Market in 2024?

The market valuation for the Agriculture Biological Control Agents Market in 2024 was 7.813 USD Billion. Read More

What is the expected CAGR for the Agriculture Biological Control Agents Market during the forecast period 2025 - 2035?

The expected CAGR for the Agriculture Biological Control Agents Market during the forecast period 2025 - 2035 is 9.26%. Read More

Which company is a key player in the Agriculture Biological Control Agents Market?

Key players in the Agriculture Biological Control Agents Market include BASF SE, Syngenta AG, and Bayer AG. Read More

What segment of the Agriculture Biological Control Agents Market had the highest valuation in 2024?

In 2024, the segment of Bioinsecticides had a valuation of 1.8 USD Billion. Read More

What is the projected valuation for the Soil Application segment by 2035?

The projected valuation for the Soil Application segment by 2035 is 6.5 USD Billion. Read More

How does the valuation of Natural Predators compare to that of Bioinsecticides in 2024?

In 2024, the valuation of Natural Predators was 1.2 USD Billion, which is lower than the 1.8 USD Billion valuation of Bioinsecticides. Read More

What is the expected market size for Foliar Application by 2035?

The expected market size for Foliar Application by 2035 is 8.0 USD Billion. Read More

Which crop type is projected to have a valuation of 5.7 USD Billion by 2035?

The Fruit and Vegetable Crops segment is projected to have a valuation of 5.7 USD Billion by 2035. Read More

What formulation type is expected to reach a valuation of 7.5 USD Billion by 2035?

Granular Formulations are expected to reach a valuation of 7.5 USD Billion by 2035. Read More

Agriculture Biological Control Agents Market

ID: MRFR/Agri/29802-HCR

128 Pages

Snehal Singh

Last Updated: April 06, 2026

Agriculture Biological Control Agents Market Size, Share, Industry Trend & Analysis Research Report By Agent Type (Microbial Control Agents, Natural Predators, Bioinsecticides, Biopesticides, Entomopathogenic Nematodes), By Application Method (Soil Application, Foliar Application, Seed Treatment), By Crop Type (Field Crops, Horticultural Crops, Ornamental Plants, Fruit and Vegetable Crops), By Functionality (Pest Control, Disease Control, Weed Control), By Formulation Type (Liquid Formulations, Granular Formulations, Powder Formulations) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035.

Agriculture Biological Control Agents Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.26%

2024 Market Size$ 7.81 Billion

2025 Market Size$ 8.54 Billion

2035 Market Size$ 20.7 Billion

Key Players

BASF SE

Syngenta AG

Bayer AG

Corteva Agriscience

FMC Corporation

Valent BioSciences LLC

Trends

Rising Demand for Sustainable Solutions
Advancements in Biotechnology
Regulatory Support for Biological Methods

Opportunities

Rising Organic Farming Practices
Increasing Awareness of Environmental Impact
Supportive Government Policies and Incentives

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Agent Type (USD Billion)
  1. 4.1.1 Microbial Control Agents
  2. 4.1.2 Natural Predators
  3. 4.1.3 Bioinsecticides
  4. 4.1.4 Biopesticides
  5. 4.1.5 Entomopathogenic Nematodes
2. 4.2 Pharmaceutical, BY Application Method (USD Billion)
  1. 4.2.1 Soil Application
  2. 4.2.2 Foliar Application
  3. 4.2.3 Seed Treatment
3. 4.3 Pharmaceutical, BY Crop Type (USD Billion)
  1. 4.3.1 Field Crops
  2. 4.3.2 Horticultural Crops
  3. 4.3.3 Ornamental Plants
  4. 4.3.4 Fruit and Vegetable Crops
4. 4.4 Pharmaceutical, BY Functionality (USD Billion)
  1. 4.4.1 Pest Control
  2. 4.4.2 Disease Control
  3. 4.4.3 Weed Control
5. 4.5 Pharmaceutical, BY Formulation Type (USD Billion)
  1. 4.5.1 Liquid Formulations
  2. 4.5.2 Granular Formulations
  3. 4.5.3 Powder Formulations
6. 4.6 Pharmaceutical, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 BASF SE (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Syngenta AG (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bayer AG (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Corteva Agriscience (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 FMC Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Valent BioSciences LLC (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Certis USA LLC (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Koppert Biological Systems (NL)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Biobest Group NV (BE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY AGENT TYPE
4. 6.4 US MARKET ANALYSIS BY APPLICATION METHOD
5. 6.5 US MARKET ANALYSIS BY CROP TYPE
6. 6.6 US MARKET ANALYSIS BY FUNCTIONALITY
7. 6.7 US MARKET ANALYSIS BY FORMULATION TYPE
8. 6.8 CANADA MARKET ANALYSIS BY AGENT TYPE
9. 6.9 CANADA MARKET ANALYSIS BY APPLICATION METHOD
10. 6.10 CANADA MARKET ANALYSIS BY CROP TYPE
11. 6.11 CANADA MARKET ANALYSIS BY FUNCTIONALITY
12. 6.12 CANADA MARKET ANALYSIS BY FORMULATION TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY AGENT TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION METHOD
16. 6.16 GERMANY MARKET ANALYSIS BY CROP TYPE
17. 6.17 GERMANY MARKET ANALYSIS BY FUNCTIONALITY
18. 6.18 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
19. 6.19 UK MARKET ANALYSIS BY AGENT TYPE
20. 6.20 UK MARKET ANALYSIS BY APPLICATION METHOD
21. 6.21 UK MARKET ANALYSIS BY CROP TYPE
22. 6.22 UK MARKET ANALYSIS BY FUNCTIONALITY
23. 6.23 UK MARKET ANALYSIS BY FORMULATION TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY AGENT TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY APPLICATION METHOD
26. 6.26 FRANCE MARKET ANALYSIS BY CROP TYPE
27. 6.27 FRANCE MARKET ANALYSIS BY FUNCTIONALITY
28. 6.28 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY AGENT TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY APPLICATION METHOD
31. 6.31 RUSSIA MARKET ANALYSIS BY CROP TYPE
32. 6.32 RUSSIA MARKET ANALYSIS BY FUNCTIONALITY
33. 6.33 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
34. 6.34 ITALY MARKET ANALYSIS BY AGENT TYPE
35. 6.35 ITALY MARKET ANALYSIS BY APPLICATION METHOD
36. 6.36 ITALY MARKET ANALYSIS BY CROP TYPE
37. 6.37 ITALY MARKET ANALYSIS BY FUNCTIONALITY
38. 6.38 ITALY MARKET ANALYSIS BY FORMULATION TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY AGENT TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY APPLICATION METHOD
41. 6.41 SPAIN MARKET ANALYSIS BY CROP TYPE
42. 6.42 SPAIN MARKET ANALYSIS BY FUNCTIONALITY
43. 6.43 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY AGENT TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION METHOD
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY CROP TYPE
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY FUNCTIONALITY
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY AGENT TYPE
51. 6.51 CHINA MARKET ANALYSIS BY APPLICATION METHOD
52. 6.52 CHINA MARKET ANALYSIS BY CROP TYPE
53. 6.53 CHINA MARKET ANALYSIS BY FUNCTIONALITY
54. 6.54 CHINA MARKET ANALYSIS BY FORMULATION TYPE
55. 6.55 INDIA MARKET ANALYSIS BY AGENT TYPE
56. 6.56 INDIA MARKET ANALYSIS BY APPLICATION METHOD
57. 6.57 INDIA MARKET ANALYSIS BY CROP TYPE
58. 6.58 INDIA MARKET ANALYSIS BY FUNCTIONALITY
59. 6.59 INDIA MARKET ANALYSIS BY FORMULATION TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY AGENT TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY APPLICATION METHOD
62. 6.62 JAPAN MARKET ANALYSIS BY CROP TYPE
63. 6.63 JAPAN MARKET ANALYSIS BY FUNCTIONALITY
64. 6.64 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY AGENT TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION METHOD
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY CROP TYPE
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY FUNCTIONALITY
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY AGENT TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION METHOD
72. 6.72 MALAYSIA MARKET ANALYSIS BY CROP TYPE
73. 6.73 MALAYSIA MARKET ANALYSIS BY FUNCTIONALITY
74. 6.74 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY AGENT TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY APPLICATION METHOD
77. 6.77 THAILAND MARKET ANALYSIS BY CROP TYPE
78. 6.78 THAILAND MARKET ANALYSIS BY FUNCTIONALITY
79. 6.79 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY AGENT TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY APPLICATION METHOD
82. 6.82 INDONESIA MARKET ANALYSIS BY CROP TYPE
83. 6.83 INDONESIA MARKET ANALYSIS BY FUNCTIONALITY
84. 6.84 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY AGENT TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION METHOD
87. 6.87 REST OF APAC MARKET ANALYSIS BY CROP TYPE
88. 6.88 REST OF APAC MARKET ANALYSIS BY FUNCTIONALITY
89. 6.89 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY AGENT TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY APPLICATION METHOD
93. 6.93 BRAZIL MARKET ANALYSIS BY CROP TYPE
94. 6.94 BRAZIL MARKET ANALYSIS BY FUNCTIONALITY
95. 6.95 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY AGENT TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY APPLICATION METHOD
98. 6.98 MEXICO MARKET ANALYSIS BY CROP TYPE
99. 6.99 MEXICO MARKET ANALYSIS BY FUNCTIONALITY
100. 6.100 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY AGENT TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION METHOD
103. 6.103 ARGENTINA MARKET ANALYSIS BY CROP TYPE
104. 6.104 ARGENTINA MARKET ANALYSIS BY FUNCTIONALITY
105. 6.105 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGENT TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION METHOD
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY CROP TYPE
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNCTIONALITY
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY AGENT TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION METHOD
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY CROP TYPE
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY FUNCTIONALITY
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY AGENT TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION METHOD
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY CROP TYPE
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY FUNCTIONALITY
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY AGENT TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION METHOD
124. 6.124 REST OF MEA MARKET ANALYSIS BY CROP TYPE
125. 6.125 REST OF MEA MARKET ANALYSIS BY FUNCTIONALITY
126. 6.126 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
127. 6.127 KEY BUYING CRITERIA OF PHARMACEUTICAL
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF PHARMACEUTICAL
130. 6.130 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
131. 6.131 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
132. 6.132 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
133. 6.133 PHARMACEUTICAL, BY AGENT TYPE, 2024 (% SHARE)
134. 6.134 PHARMACEUTICAL, BY AGENT TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 PHARMACEUTICAL, BY APPLICATION METHOD, 2024 (% SHARE)
136. 6.136 PHARMACEUTICAL, BY APPLICATION METHOD, 2024 TO 2035 (USD Billion)
137. 6.137 PHARMACEUTICAL, BY CROP TYPE, 2024 (% SHARE)
138. 6.138 PHARMACEUTICAL, BY CROP TYPE, 2024 TO 2035 (USD Billion)
139. 6.139 PHARMACEUTICAL, BY FUNCTIONALITY, 2024 (% SHARE)
140. 6.140 PHARMACEUTICAL, BY FUNCTIONALITY, 2024 TO 2035 (USD Billion)
141. 6.141 PHARMACEUTICAL, BY FORMULATION TYPE, 2024 (% SHARE)
142. 6.142 PHARMACEUTICAL, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.2.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.2.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.2.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.3.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.3.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.3.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.4.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.4.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.4.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.5.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.5.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.5.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.6.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.6.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.6.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.7.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.7.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.7.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.8.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.8.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.8.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.9.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.9.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.9.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.10.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.10.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.10.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.11.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.11.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.11.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.12.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.12.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.12.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.13.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.13.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.13.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.14.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.14.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.14.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.15.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.15.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.15.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.16.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.16.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.16.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.17.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.17.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.17.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.18.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.18.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.18.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.19.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.19.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.19.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.20.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.20.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.20.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.21.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.21.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.21.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.22.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.22.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.22.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.23.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.23.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.23.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.24.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.24.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.24.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.25.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.25.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.25.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.26.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.26.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.26.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.27.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.27.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.27.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.28.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.28.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.28.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.29.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.29.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.29.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY AGENT TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
  3. 7.30.3 BY CROP TYPE, 2025-2035 (USD Billion)
  4. 7.30.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
  5. 7.30.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Pharmaceutical Market Segmentation

Pharmaceutical By Agent Type (USD Billion, 2025-2035)

Microbial Control Agents
Natural Predators
Bioinsecticides
Biopesticides
Entomopathogenic Nematodes

Pharmaceutical By Application Method (USD Billion, 2025-2035)

Soil Application
Foliar Application
Seed Treatment

Pharmaceutical By Crop Type (USD Billion, 2025-2035)

Field Crops
Horticultural Crops
Ornamental Plants
Fruit and Vegetable Crops

Pharmaceutical By Functionality (USD Billion, 2025-2035)

Pest Control
Disease Control
Weed Control

Pharmaceutical By Formulation Type (USD Billion, 2025-2035)

Liquid Formulations
Granular Formulations
Powder Formulations

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”